52 related articles for article (PubMed ID: 23991727)
1. Immunohistochemical panel to characterize canine prostate carcinomas according to aberrant p63 expression.
Fonseca-Alves CE; Kobayashi PE; Rivera Calderón LG; Felisbino SL; Rinaldi JC; Drigo SA; Rogatto SR; Laufer-Amorim R
PLoS One; 2018; 13(6):e0199173. PubMed ID: 29894516
[TBL] [Abstract][Full Text] [Related]
2. Basal cell hyperplasia and basal cell carcinoma of the prostate: a comprehensive review and discussion of a case with c-erbB-2 expression.
Montironi R; Mazzucchelli R; Stramazzotti D; Scarpelli M; López Beltran A; Bostwick DG
J Clin Pathol; 2005 Mar; 58(3):290-6. PubMed ID: 15735163
[TBL] [Abstract][Full Text] [Related]
3. Bad seeds produce bad crops: a single stage-process of prostate tumor invasion.
Man YG; Gardner WA
Int J Biol Sci; 2008 Aug; 4(4):246-58. PubMed ID: 18725981
[TBL] [Abstract][Full Text] [Related]
4. Deep learning approach for accurate prostate cancer identification and stratification using combined immunostaining of cytokeratin, p63, and racemase.
Salvi M; Manini C; López JI; Fenoglio D; Molinari F
Comput Med Imaging Graph; 2023 Oct; 109():102288. PubMed ID: 37633031
[TBL] [Abstract][Full Text] [Related]
5. Correlated alterations in prostate basal cell layer and basement membrane.
Liu A; Wei L; Gardner WA; Deng CX; Man YG
Int J Biol Sci; 2009; 5(3):276-85. PubMed ID: 19343113
[TBL] [Abstract][Full Text] [Related]
6. Editorial Comment to Primary basal cell carcinoma of the prostate with concurrent adenocarcinoma.
Funahashi Y
IJU Case Rep; 2020 Mar; 3(2):61. PubMed ID: 32743471
[No Abstract] [Full Text] [Related]
7. Prostate adenocarcinomas aberrantly expressing p63 are molecularly distinct from usual-type prostatic adenocarcinomas.
Tan HL; Haffner MC; Esopi DM; Vaghasia AM; Giannico GA; Ross HM; Ghosh S; Hicks JL; Zheng Q; Sangoi AR; Yegnasubramanian S; Osunkoya AO; De Marzo AM; Epstein JI; Lotan TL
Mod Pathol; 2015 Mar; 28(3):446-56. PubMed ID: 25216229
[TBL] [Abstract][Full Text] [Related]
8. Aberrant Expression of p63 in an Adenocarcinoma of the Prostate That Has Metastasized to the Oral Cavity.
Khalid R; Ramanathan A; Tee Lun H; Lim D
Cureus; 2022 Mar; 14(3):e22753. PubMed ID: 35371862
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic utility of a-methylacyl COA racemase in prostate cancer of the Iranian population.
Taheri D; Roohani E; Izadpanahi MH; Dolatkhah S; Aghaaliakbari F; Daneshpajouhnejad P; Gharaati MR; Mazdak H; Fesharakizadeh S; Beinabadi Y; Kazemi R; Rahbar M
J Res Med Sci; 2021; 26():46. PubMed ID: 34484378
[TBL] [Abstract][Full Text] [Related]
10. TAp63 and ΔNp63 (p40) in prostate adenocarcinomas: ΔNp63 associates with a basal-like cancer stem cell population but not with metastasis.
Galoczova M; Nenutil R; Pokorna Z; Vojtesek B; Coates PJ
Virchows Arch; 2021 Apr; 478(4):627-636. PubMed ID: 33037932
[TBL] [Abstract][Full Text] [Related]
11. The pathology of unusual subtypes of prostate cancer.
Li J; Wang Z
Chin J Cancer Res; 2016 Feb; 28(1):130-43. PubMed ID: 27041935
[TBL] [Abstract][Full Text] [Related]
12. HOXB13 G84E-related familial prostate cancers: a clinical, histologic, and molecular survey.
Smith SC; Palanisamy N; Zuhlke KA; Johnson AM; Siddiqui J; Chinnaiyan AM; Kunju LP; Cooney KA; Tomlins SA
Am J Surg Pathol; 2014 May; 38(5):615-26. PubMed ID: 24722062
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical antibody cocktail staining (p63/HMWCK/AMACR) of ductal adenocarcinoma and Gleason pattern 4 cribriform and noncribriform acinar adenocarcinomas of the prostate.
Herawi M; Epstein JI
Am J Surg Pathol; 2007 Jun; 31(6):889-94. PubMed ID: 17527076
[TBL] [Abstract][Full Text] [Related]
14. Alpha-methylacyl-CoA racemase (P504S)/34betaE12/p63 triple cocktail stain in prostatic adenocarcinoma after hormonal therapy.
Sung MT; Jiang Z; Montironi R; MacLennan GT; Mazzucchelli R; Cheng L
Hum Pathol; 2007 Feb; 38(2):332-41. PubMed ID: 17134736
[TBL] [Abstract][Full Text] [Related]
15. Comparison of annexin II, p63 and alpha-methylacyl-CoA racemase immunoreactivity in prostatic tissue: a tissue microarray study.
Stewart J; Fleshner N; Cole H; Sweet J
J Clin Pathol; 2007 Jul; 60(7):773-80. PubMed ID: 16916997
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical pitfalls in prostate pathology.
Brimo F; Epstein JI
Hum Pathol; 2012 Mar; 43(3):313-24. PubMed ID: 22325142
[TBL] [Abstract][Full Text] [Related]
17. Application of alpha-methylacyl coenzyme A racemase immunohistochemistry in the diagnosis of prostate cancer: a review.
Adley BP; Yang XJ
Anal Quant Cytol Histol; 2006 Feb; 28(1):1-13. PubMed ID: 16566275
[TBL] [Abstract][Full Text] [Related]
18. Prostate cancer with aberrant diffuse p63 expression: report of a case and review of the literature and morphologic mimics.
Wu A; Kunju LP
Arch Pathol Lab Med; 2013 Sep; 137(9):1179-84. PubMed ID: 23991727
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
